Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil

Tauil, Márcia de Cantuária; Carvalho, Cleidiane Santos Rodrigues de; Vieira, Ataiza César; Waldman, Eliseu Alves.
Braz. j. infect. dis ; 18(4): 379-386, Jul-Aug/2014. tab, graf
Artigo em Inglês | LILACS | ID: lil-719306

Documentos relacionados

  1. Inference of transmission dynamics and retrospective forecast of invasive meningococcal disease.
  2. Impact of Meningococcal ACWY Vaccination Program during 2017-18 Epidemic, Western Australia, Australia.
  3. Pediatric Invasive Meningococcal Disease, Auckland, New Zealand (Aotearoa), 2004-2020.
  4. Analysis of meningococcal vaccine uptake in patients with invasive meningococcal disease, Czech Republic, 2006-2022.
  5. Characterisation of Neisseria meningitidis cc11/ET-15 variant by whole genome sequencing.
  6. Informing the use of a supplementary immunisation programme for the management of a community cluster of invasive meningococcal disease, Yorkshire, 2022.
  7. Carriage prevalence of Neisseria meningitidis in China, 2005-2022: a systematic review and meta-analysis.
  8. Effectiveness of Meningococcal Vaccines at Reducing Invasive Meningococcal Disease and Pharyngeal Neisseria meningitidis Carriage: A Systematic Review and Meta-analysis.
  9. B Part of It School Leaver Study: A Repeat Cross-Sectional Study to Assess the Impact of Increasing Coverage With Meningococcal B (4CMenB) Vaccine on Carriage of Neisseria meningitidis.
  10. Molecular characteristics of Neisseria meningitidis carriage strains in university students in Lithuania.